Ranbaxy Wins Approval for First Generic of Novartis’ Diovan

Drug Industry Daily
A A
Generics maker Ranbaxy has the green light to launch an exclusive version of Novartis’ blockbuster hypertension drug Diovan, a move that comes nearly two years after the drug lost patent protection.

To View This Article:

Login

Subscribe To Drug Industry Daily